Bouzari

BOUZARI is a New York-based biotechnology company focused on accelerating the development of novel medicines for patients with unmet medical needs. Founded by Farzad Bouzari, the company leverages a science-first, platform-based approach to identify and develop therapeutic candidates across oncology, neurology, and inflammation. BOUZARI's pipeline consists of several early-stage programs, including small molecules and monoclonal antibodies, aimed at targeting key disease pathways. The company aims to redefine the traditional drug development model through rigorous scientific validation and efficient clinical translation.